[1] DeLuca is well known for his research involving Vitamin D, from which several pharmaceutical drugs are derived, including those to treat conditions such as kidney failure, osteoporosis, and psoriasis.
Licensing of his technology, through the Wisconsin Alumni Research Foundation, has generated tens of millions of dollars in revenue for the university.
[4] In addition, DeLuca was the founder of Deltanoid Pharmaceuticals, a biotechnology company.
[6] He was elected to the United States National Academy of Sciences in 1979.
[7] He was awarded the Bolton S. Corson Medal of the Franklin Institute in 1985.